|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5367066A
(en)
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
|
FR2575751B1
(fr)
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
|
US4751219A
(en)
|
1985-02-05 |
1988-06-14 |
Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek |
Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
CA1340032C
(en)
|
1987-06-24 |
1998-09-08 |
Jim Haralambidis |
Lucleoside derivatives
|
|
US5175273A
(en)
|
1988-07-01 |
1992-12-29 |
Genentech, Inc. |
Nucleic acid intercalating agents
|
|
US5256775A
(en)
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
US5264562A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences, Inc. |
Oligonucleotide analogs with novel linkages
|
|
US5264564A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences |
Oligonucleotide analogs with novel linkages
|
|
DE69034150T2
(de)
|
1989-10-24 |
2005-08-25 |
Isis Pharmaceuticals, Inc., Carlsbad |
2'-Modifizierte Oligonukleotide
|
|
US5177198A
(en)
|
1989-11-30 |
1993-01-05 |
University Of N.C. At Chapel Hill |
Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
|
|
US5130302A
(en)
|
1989-12-20 |
1992-07-14 |
Boron Bilogicals, Inc. |
Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
|
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5587470A
(en)
|
1990-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
|
US5681941A
(en)
|
1990-01-11 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
DK0455905T3
(da)
|
1990-05-11 |
1998-12-07 |
Microprobe Corp |
Dipsticks til nukleinsyrehybridiseringsassays og fremgangsmåde til kovalent immobilisering af oligonukleotider
|
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
|
US5386023A
(en)
|
1990-07-27 |
1995-01-31 |
Isis Pharmaceuticals |
Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
|
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
|
WO1992002258A1
(en)
|
1990-07-27 |
1992-02-20 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression
|
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
|
US5223618A
(en)
|
1990-08-13 |
1993-06-29 |
Isis Pharmaceuticals, Inc. |
4'-desmethyl nucleoside analog compounds
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
ATE226093T1
(de)
|
1991-11-26 |
2002-11-15 |
Isis Pharmaceuticals Inc |
Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen
|
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
|
TW393513B
(en)
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
US5434257A
(en)
|
1992-06-01 |
1995-07-18 |
Gilead Sciences, Inc. |
Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
JPH08502723A
(ja)
|
1992-07-27 |
1996-03-26 |
ハイブライドン インコーポレイテッド |
オリゴヌクレオチド・アルキルホスホノチオエート
|
|
DK0677056T3
(da)
|
1993-01-25 |
1996-08-05 |
Hybridon Inc |
Oligonukleotid-alkylphosphonater og -alkylphosphonothioater
|
|
US5476925A
(en)
|
1993-02-01 |
1995-12-19 |
Northwestern University |
Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
|
|
GB9304620D0
(en)
|
1993-03-06 |
1993-04-21 |
Ciba Geigy Ag |
Compounds
|
|
EP0691968B1
(en)
|
1993-03-30 |
1997-07-16 |
Sanofi |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
|
US5502177A
(en)
|
1993-09-17 |
1996-03-26 |
Gilead Sciences, Inc. |
Pyrimidine derivatives for labeled binding partners
|
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5625050A
(en)
|
1994-03-31 |
1997-04-29 |
Amgen Inc. |
Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
|
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
US5599706A
(en)
|
1994-09-23 |
1997-02-04 |
Stinchcomb; Dan T. |
Ribozymes targeted to apo(a) mRNA
|
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
|
US6908903B1
(en)
|
1994-12-07 |
2005-06-21 |
Aletheon Pharmaceuticals, Inc. |
Cluster clearing agents
|
|
US6172045B1
(en)
|
1994-12-07 |
2001-01-09 |
Neorx Corporation |
Cluster clearing agents
|
|
JP2000501414A
(ja)
|
1995-11-22 |
2000-02-08 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
生体分子の細胞取り込みを高めるリガンド
|
|
US20030119724A1
(en)
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
|
US5998203A
(en)
|
1996-04-16 |
1999-12-07 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
|
|
CN1231675A
(zh)
|
1996-09-26 |
1999-10-13 |
味之素株式会社 |
修饰的生理活性蛋白及含有该蛋白的药物组合物
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
DE69829760T3
(de)
|
1997-09-12 |
2016-04-14 |
Exiqon A/S |
Bi- und tri-zyklische - nukleosid, nukleotid und oligonukleotid-analoga
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
|
US6300319B1
(en)
|
1998-06-16 |
2001-10-09 |
Isis Pharmaceuticals, Inc. |
Targeted oligonucleotide conjugates
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
US6166239A
(en)
|
1998-09-04 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide protecting groups
|
|
US20030170249A1
(en)
|
1999-02-19 |
2003-09-11 |
Hakomori Sen-Itiroh |
Vaccines directed to cancer-associated carbohydrate antigens
|
|
KR20070118315A
(ko)
|
1999-04-21 |
2007-12-14 |
와이어쓰 |
폴리뉴클레오티드 서열의 기능을 억제하기 위한 조성물
|
|
KR100782896B1
(ko)
|
1999-05-04 |
2007-12-06 |
엑시콘 에이/에스 |
Ｌ-리보-ｌｎａ 유사체
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
US6383812B1
(en)
|
1999-05-28 |
2002-05-07 |
Academia Sinica |
Anti liver disease drug R-YEEE and method of synthesizing branched galactose-terminal glycoproteins
|
|
US20080281041A1
(en)
|
1999-06-07 |
2008-11-13 |
Rozema David B |
Reversibly Masked Polymers
|
|
US8541548B2
(en)
|
1999-06-07 |
2013-09-24 |
Arrowhead Madison Inc. |
Compounds and methods for reversible modification of biologically active molecules
|
|
CA2379152A1
(en)
|
1999-07-16 |
2001-01-25 |
Hyseq, Inc. |
Novel angiopoietin materials and methods
|
|
HK1045541A1
(en)
|
1999-12-09 |
2002-11-29 |
Sankyo Company, Limited |
Method of testing remedy or preventive for hyperlipemia
|
|
EP1244667B1
(en)
|
1999-12-30 |
2006-04-05 |
K.U. Leuven Research & Development |
Cyclohexene nucleic acids
|
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
CA2431839A1
(en)
|
2000-12-01 |
2002-06-06 |
Paul O. P. Ts'o |
Conjugates of glycosylated/galactosylated peptide
|
|
US20030077829A1
(en)
|
2001-04-30 |
2003-04-24 |
Protiva Biotherapeutics Inc.. |
Lipid-based formulations
|
|
IL159153A0
(en)
|
2001-06-08 |
2004-06-01 |
Sankyo Co |
Methods for testing drugs for treating or preventing diseases such as hyperlipidemia
|
|
CA2452458A1
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
|
US7407943B2
(en)
|
2001-08-01 |
2008-08-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of apolipoprotein B expression
|
|
US7227014B2
(en)
|
2001-08-07 |
2007-06-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of apolipoprotein (a) expression
|
|
US7259150B2
(en)
|
2001-08-07 |
2007-08-21 |
Isis Pharmaceuticals, Inc. |
Modulation of apolipoprotein (a) expression
|
|
WO2003014397A1
(en)
|
2001-08-09 |
2003-02-20 |
Biomedlab Corporation |
Probe for detection of enteric virus detection kit and method for enteric virus with the same
|
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
|
ES2429034T3
(es)
|
2001-11-16 |
2013-11-12 |
Genentech, Inc. |
Uso de antagonistas de ANGPTL3 para el tratamiento de enfermedades hepáticas
|
|
US20100240730A1
(en)
|
2002-02-20 |
2010-09-23 |
Merck Sharp And Dohme Corp. |
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
|
|
EP1543019A2
(en)
|
2002-09-11 |
2005-06-22 |
Santaris Pharma A/S |
Modified pna molecules
|
|
CA2502649A1
(en)
|
2002-10-18 |
2004-04-29 |
Nucleonics Inc. |
Double-stranded rna structures and constructs, and methods for generating and using the same
|
|
CA2504694C
(en)
|
2002-11-05 |
2013-10-01 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
AU2003291755A1
(en)
|
2002-11-05 |
2004-06-07 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
|
|
CA2505801A1
(en)
|
2002-11-13 |
2004-05-27 |
Rosanne Crooke |
Antisense modulation of apolipoprotein b expression
|
|
US7511131B2
(en)
|
2002-11-13 |
2009-03-31 |
Genzyme Corporation |
Antisense modulation of apolipoprotein B expression
|
|
US20060009410A1
(en)
|
2002-11-13 |
2006-01-12 |
Crooke Rosanne M |
Effects of apolipoprotein B inhibition on gene expression profiles in animals
|
|
JP2006507841A
(ja)
|
2002-11-14 |
2006-03-09 |
ダーマコン， インコーポレイテッド |
機能的ｓｉＲＮＡおよび超機能的ｓｉＲＮＡ
|
|
US20070015927A1
(en)
|
2003-01-09 |
2007-01-18 |
Kim Byeang H |
New phosphoramidite compounds
|
|
ATE479752T1
(de)
|
2003-03-07 |
2010-09-15 |
Alnylam Pharmaceuticals Inc |
Therapeutische zusammensetzungen
|
|
US7598227B2
(en)
|
2003-04-16 |
2009-10-06 |
Isis Pharmaceuticals Inc. |
Modulation of apolipoprotein C-III expression
|
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
|
WO2004094595A2
(en)
|
2003-04-17 |
2004-11-04 |
Alnylam Pharmaceuticals Inc. |
MODIFIED iRNA AGENTS
|
|
US7851615B2
(en)
|
2003-04-17 |
2010-12-14 |
Alnylam Pharmaceuticals, Inc. |
Lipophilic conjugated iRNA agents
|
|
JPWO2004101619A1
(ja)
|
2003-05-15 |
2006-10-26 |
塩野義製薬株式会社 |
機能的糖ペプチドの合理的設計および合成
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
JP4731324B2
(ja)
|
2003-08-28 |
2011-07-20 |
武 今西 |
Ｎ−ｏ結合性架橋構造型新規人工核酸
|
|
AU2004274021B2
(en)
|
2003-09-18 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
|
JPWO2005097155A1
(ja)
|
2004-04-08 |
2008-02-28 |
タカラバイオ株式会社 |
神経突起伸長誘導剤
|
|
AU2005248147A1
(en)
|
2004-05-11 |
2005-12-08 |
Alphagen Co., Ltd. |
Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same
|
|
EP1765416A4
(en)
|
2004-06-03 |
2010-03-24 |
Isis Pharmaceuticals Inc |
DOUBLE-STRONG COMPOSITIONS WITH DIFFERENTLY MODIFIED STRANDS FOR USE IN GENE MODULATION
|
|
LT1781698T
(lt)
|
2004-07-20 |
2016-09-26 |
Genentech, Inc. |
Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai
|
|
DK2997980T3
(en)
|
2004-08-10 |
2018-03-26 |
Kastle Therapeutics Llc |
PROCEDURES FOR MODULATING LIPROPROTEIN AND CHOLESTEROL LEVELS
|
|
US7582744B2
(en)
|
2004-08-10 |
2009-09-01 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides
|
|
US20090203132A1
(en)
|
2004-09-09 |
2009-08-13 |
Swayze Eric E |
Pyrrolidinyl groups for attaching conjugates to oligomeric compounds
|
|
WO2006047842A2
(en)
|
2004-11-08 |
2006-05-11 |
K.U. Leuven Research And Development |
Modified nucleosides for rna interference
|
|
US20060148740A1
(en)
|
2005-01-05 |
2006-07-06 |
Prosensa B.V. |
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
|
|
US20080206869A1
(en)
|
2005-01-24 |
2008-08-28 |
Avaris Ab |
Nucleic Acid Complex
|
|
WO2007035759A1
(en)
|
2005-09-19 |
2007-03-29 |
Johnson & Johnson Pharmaceutical Research & Development L.L.C. |
Modulation of glucocorticoid receptor expression
|
|
US7569686B1
(en)
|
2006-01-27 |
2009-08-04 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for synthesis of bicyclic nucleic acid analogs
|
|
US7399845B2
(en)
|
2006-01-27 |
2008-07-15 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
JP5731115B2
(ja)
|
2006-05-05 |
2015-06-10 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
遺伝子発現を調節するための化合物および方法
|
|
AU2007249349B2
(en)
|
2006-05-11 |
2012-03-08 |
Isis Pharmaceuticals, Inc. |
5'-Modified bicyclic nucleic acid analogs
|
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
|
CA2660052A1
(en)
|
2006-08-04 |
2008-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the modulation of jnk proteins
|
|
KR101133799B1
(ko)
|
2006-08-18 |
2012-04-24 |
에프. 호프만-라 로슈 아게 |
폴리뉴클레오타이드의 생체내 전달을 위한 다가접합체
|
|
US8658211B2
(en)
|
2006-08-18 |
2014-02-25 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
|
US8093222B2
(en)
|
2006-11-27 |
2012-01-10 |
Isis Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia
|
|
HUE033960T2
(en)
|
2006-12-08 |
2018-01-29 |
Lexicon Pharmaceuticals Inc |
Monoclonal Antibodies to ANGPTL3
|
|
US20100190837A1
(en)
|
2007-02-15 |
2010-07-29 |
Isis Pharmaceuticals, Inc. |
5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
|
|
EP2604284A1
(en)
|
2007-02-16 |
2013-06-19 |
KTB Tumorforschungsgesellschaft mbH |
Receptor And Antigen Targeted Prodrug
|
|
WO2008131419A2
(en)
|
2007-04-23 |
2008-10-30 |
Alnylam Pharmaceuticals, Inc. |
Glycoconjugates of rna interference agents
|
|
WO2008150729A2
(en)
|
2007-05-30 |
2008-12-11 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
DK2173760T4
(en)
|
2007-06-08 |
2016-02-08 |
Isis Pharmaceuticals Inc |
Carbocyclic bicyclic nukleinsyreanaloge
|
|
WO2009003009A1
(en)
|
2007-06-26 |
2008-12-31 |
Enanta Pharmaceuticals, Inc. |
Substituted pyrrolidine as anti-infectives
|
|
ATE538127T1
(de)
|
2007-07-05 |
2012-01-15 |
Isis Pharmaceuticals Inc |
6-disubstituierte bicyclische nukleinsäureanaloga
|
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
|
US20090247608A1
(en)
|
2007-12-04 |
2009-10-01 |
Alnylam Pharmaceuticals, Inc. |
Targeting Lipids
|
|
EP2245039A4
(en)
|
2008-01-31 |
2012-06-06 |
Alnylam Pharmaceuticals Inc |
OPTIMIZED METHODS FOR EXPORING DSRNA TO TARGET THE PCSK9 GEN
|
|
US8530640B2
(en)
|
2008-02-07 |
2013-09-10 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
WO2009142822A2
(en)
|
2008-03-26 |
2009-11-26 |
Alnylam Pharmaceuticals, Inc. |
2-f modified rna interference agents
|
|
EP3604533A1
(en)
|
2008-04-11 |
2020-02-05 |
Arbutus Biopharma Corporation |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
WO2009143369A2
(en)
|
2008-05-22 |
2009-11-26 |
Isis Pharmaceuticals, Inc. |
Method of preparing nucleosides and analogs thereof without using chromatography
|
|
JP2012513953A
(ja)
|
2008-09-23 |
2012-06-21 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
付加環化を用いたモノマーおよびオリゴヌクレオチドの化学修飾
|
|
DK2356129T3
(da)
|
2008-09-24 |
2013-05-13 |
Isis Pharmaceuticals Inc |
Substituerede alpha-L-bicykliske nukleosider
|
|
DK2361256T3
(da)
|
2008-09-24 |
2013-07-01 |
Isis Pharmaceuticals Inc |
Cyclohexenyl-nukleinsyreanaloger
|
|
US8987435B2
(en)
|
2008-10-24 |
2015-03-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
JP5763539B2
(ja)
|
2008-10-24 |
2015-08-12 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
５’及び２’ビス置換ヌクレオシド及びそれから製造されるオリゴマー化合物
|
|
CA2743139C
(en)
|
2008-11-10 |
2019-04-02 |
Alnylam Pharmaceuticals, Inc. |
Novel lipids and compositions for the delivery of therapeutics
|
|
EP2405921A4
(en)
|
2009-01-26 |
2013-05-22 |
Protiva Biotherapeutics Inc |
COMPOSITIONS AND METHODS FOR INACTIVATION OF APOLIPOPROTEIN C-III EXPRESSION
|
|
EP3243504A1
(en)
|
2009-01-29 |
2017-11-15 |
Arbutus Biopharma Corporation |
Improved lipid formulation
|
|
EP3424939A1
(en)
|
2009-03-02 |
2019-01-09 |
Alnylam Pharmaceuticals Inc. |
Nucleic acid chemical modifications
|
|
FR2943060B1
(fr)
|
2009-03-13 |
2013-01-04 |
Commissariat Energie Atomique |
Agents chelatants d'ions metalliques, leurs procedes de preparation et leurs applications
|
|
KR102229618B1
(ko)
|
2009-05-05 |
2021-03-18 |
알닐람 파마슈티칼스 인코포레이티드 |
지질 조성물
|
|
WO2010141511A2
(en)
*
|
2009-06-01 |
2010-12-09 |
Halo-Bio Rnai Therapeutics, Inc. |
Polynucleotides for multivalent rna interference, compositions and methods of use thereof
|
|
NZ622843A
(en)
|
2009-06-10 |
2015-10-30 |
Tekmira Pharmaceuticals Corp |
Improved lipid formulation
|
|
NZ597504A
(en)
|
2009-06-15 |
2013-10-25 |
Alnylam Pharmaceuticals Inc |
Lipid formulated dsrna targeting the pcsk9 gene
|
|
WO2011005861A1
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotide end caps
|
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
|
US8552163B2
(en)
|
2009-09-25 |
2013-10-08 |
Johns Hopkins University |
Liver-targeting agents and their synthesis
|
|
TWI388338B
(zh)
|
2009-10-26 |
2013-03-11 |
Iner Aec Executive Yuan |
對聚合醣鏈進行放射標誌以作為肝受體造影劑之方法
|
|
TWI391144B
(zh)
|
2009-10-26 |
2013-04-01 |
Iner Aec Executive Yuan |
一種定量肝殘餘功能的檢驗方法與其新穎肝受體造影檢驗藥劑
|
|
WO2011072290A2
(en)
|
2009-12-11 |
2011-06-16 |
The Regents Of The University Of Michigan |
Targeted dendrimer-drug conjugates
|
|
AU2011203986C1
(en)
|
2010-01-08 |
2015-03-05 |
Ionis Pharmaceuticals, Inc. |
Modulation of angiopoietin-like 3 expression
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
NZ601737A
(en)
|
2010-02-24 |
2013-06-28 |
Arrowhead Res Corp |
Compositions for targeted delivery of sirna
|
|
US9193752B2
(en)
|
2010-03-17 |
2015-11-24 |
Isis Pharmaceuticals, Inc. |
5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
WO2011120053A1
(en)
|
2010-03-26 |
2011-09-29 |
Mersana Therapeutics, Inc. |
Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
|
|
US20130109817A1
(en)
|
2010-03-26 |
2013-05-02 |
Mersana Therapeutics, Inc. |
Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use Thereof
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
KR101869570B1
(ko)
|
2010-04-28 |
2018-06-20 |
아이오니스 파마수티컬즈, 인코포레이티드 |
변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물
|
|
WO2011163121A1
(en)
|
2010-06-21 |
2011-12-29 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
|
CA2812046A1
(en)
|
2010-09-15 |
2012-03-22 |
Alnylam Pharmaceuticals, Inc. |
Modified irna agents
|
|
WO2012067970A2
(en)
|
2010-11-11 |
2012-05-24 |
Ted M Dawson |
Transcriptional repression leading to parkinson's disease
|
|
WO2012068187A1
(en)
|
2010-11-19 |
2012-05-24 |
Merck Sharp & Dohme Corp. |
Poly(amide) polymers for the delivery of oligonucleotides
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
EP3192800A1
(en)
|
2010-12-17 |
2017-07-19 |
Arrowhead Pharmaceuticals, Inc. |
Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
|
|
EP2658981B1
(en)
|
2010-12-29 |
2016-09-28 |
F.Hoffmann-La Roche Ag |
Small molecule conjugates for intracellular delivery of nucleic acids
|
|
CN107012144A
(zh)
|
2011-04-01 |
2017-08-04 |
Ionis制药公司 |
信号转导及转录激活蛋白3(stat3)表达的调节
|
|
TW201303013A
(zh)
|
2011-04-21 |
2013-01-16 |
Isis Pharmaceuticals Inc |
Ｂ型肝炎病毒（ｈｂｖ）表現之調節
|
|
SG10201604074TA
(en)
|
2011-04-21 |
2016-07-28 |
Isis Pharmaceuticals Inc |
Modulation of hepatitis b virus (hbv) expression
|
|
SG194671A1
(en)
|
2011-04-27 |
2013-12-30 |
Isis Pharmaceuticals Inc |
Modulation of apolipoprotein ciii (apociii) expression
|
|
CN107201364A
(zh)
|
2011-06-21 |
2017-09-26 |
阿尔尼拉姆医药品有限公司 |
用于抑制载脂蛋白c‑iii（apoc3）基因表达的组合物与方法
|
|
MX345095B
(es)
|
2011-06-21 |
2017-01-17 |
Alnylam Pharmaceuticals Inc |
Composiciones de arni similares a angiopoyetina 3 (angptl3) y metodos para su uso.
|
|
US20130017250A1
(en)
|
2011-07-15 |
2013-01-17 |
The Trustees Of Columbia University In The City Of New York |
Methods For High Density Lipoprotein Cholesterol Regulation
|
|
HK1199736A1
(en)
|
2011-08-26 |
2015-07-17 |
箭头研究公司 |
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
|
|
EP3453761A1
(en)
|
2011-08-29 |
2019-03-13 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
US9399775B2
(en)
|
2011-11-18 |
2016-07-26 |
Alnylam Pharmaceuticals, Inc. |
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
|
|
AU2013216852A1
(en)
|
2012-02-08 |
2014-08-21 |
Isis Pharmaceuticals, Inc. |
Methods and compositions for modulating Factor VII expression
|
|
WO2013142571A2
(en)
|
2012-03-20 |
2013-09-26 |
Cornell University |
Assays for the identification of compounds that modulate lipid homeostasis
|
|
US9133461B2
(en)
|
2012-04-10 |
2015-09-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the ALAS1 gene
|
|
TW201808342A
(zh)
|
2012-05-02 |
2018-03-16 |
喜納製藥公司 |
包含四ｇａｌｎａｃ之新穎結合物及傳送寡核苷酸之方法
|
|
US20150299696A1
(en)
|
2012-05-02 |
2015-10-22 |
Sirna Therapeutics, Inc. |
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
|
|
US9574193B2
(en)
*
|
2012-05-17 |
2017-02-21 |
Ionis Pharmaceuticals, Inc. |
Methods and compositions for modulating apolipoprotein (a) expression
|
|
US20160002624A1
(en)
|
2012-05-17 |
2016-01-07 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide compositions
|
|
SI2855500T1
(sl)
|
2012-05-24 |
2020-10-30 |
Ionis Pharmaceuticals, Inc. |
Postopki in sestavki za moduliranje izražanja apolipoproteina(A)
|
|
BR112015010116A2
(pt)
|
2012-11-15 |
2017-08-22 |
Roche Innovation Ct Copenhagen As |
COMPOSTOS CONJUGADOS ANTI-SENTIDO ANTI-ApoB
|
|
WO2014118272A1
(en)
|
2013-01-30 |
2014-08-07 |
Santaris Pharma A/S |
Antimir-122 oligonucleotide carbohydrate conjugates
|
|
HK1215718A1
(zh)
|
2013-01-30 |
2016-09-09 |
F. Hoffmann-La Roche Ag |
Lna寡核苷酸碳水化合物缀合物
|
|
SG10201803157XA
(en)
|
2013-05-01 |
2018-05-30 |
Regulus Therapeutics Inc |
Microrna compounds and methods for modulating mir-122
|
|
IL296543B2
(en)
|
2013-05-01 |
2025-02-01 |
Ionis Pharmaceuticals Inc |
Compositions and methods for modulating HBV and TTR expression
|
|
AU2013389474B2
(en)
*
|
2013-05-16 |
2018-11-15 |
Racthera Co., Ltd. |
Transplantation adjuvant in cell therapy using neural progenitor cells
|
|
CA2916252A1
(en)
|
2013-06-21 |
2014-12-24 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of target nucleic acids
|
|
JP6255092B2
(ja)
|
2013-06-27 |
2017-12-27 |
ロシュ イノベーション センター コペンハーゲン エーエス |
Ｐｃｓｋ９を標的とするアンチセンスオリゴマーおよびコンジュゲート
|
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
|
UA121656C2
(uk)
*
|
2014-05-01 |
2020-07-10 |
Айоніс Фармасьютикалз, Інк. |
Олігомерна сполука та спосіб лікування захворювання, пов'язаного з порушенням регуляції альтернативного шляху комплементу
|
|
BR122020024443B1
(pt)
|
2014-05-01 |
2022-02-22 |
Ionis Pharmaceuticals, Inc |
Composto e composição farmacêutica para modulação da expressão de angptl3
|
|
EP4534092A3
(en)
*
|
2014-05-01 |
2025-07-02 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating pkk expression
|
|
LT4119569T
(lt)
|
2015-11-06 |
2024-09-25 |
Ionis Pharmaceuticals, Inc. |
Konjuguoti priešprasmiai junginiai, skirti panaudoti terapijoje
|
|
JP7486920B2
(ja)
|
2015-11-06 |
2024-05-20 |
アイオーニス ファーマシューティカルズ， インコーポレーテッド |
アポリポタンパク質（ａ）発現の調節
|